Health Care and Rehabilitation Services (HCRS), southeastern Vermont’s nonprofit community mental-health agency, is thrilled ...

Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...

Our leadership supporting specialty providers is a key differentiator and growth driver for Cencora and we've evolved our service offerings over time. Over decades, we've deepened our ...

Through the sure supply program, providers can help lessen the impacts of shortages for at-risk treatments so they can focus on what matters most—taking care of their patients.” Cencora ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Full Year Revenue Growth Guidance: 8% to 10%. Full Year Operating Income Growth Guidance: 11.5% to 13.5%. Cencora Inc (NYSE:COR) reported a strong start to fiscal year 2025 with a 13% increase in ...

I'll begin with advancing our leadership in specialty. Our leadership supporting specialty providers is a key differentiator and growth driver for Cencora and we've evolved our service offerings over ...

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) reached a new 52-week high on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $ ...

Cencora, a global healthcare company, has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide ...

Q1 2025 Management View CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS. He attributed this success to robust execution in the U.S.